We are delighted to announce that we have opened a new facility at Mayday University Hospital to complement our units and offices in St George’s Hospital and St George’s University of London. This ground breaking move means Richmond Pharmacology is the UK’s first CROwith a dedicated Phase I and clinical trials unit to be based in 2 acute NHS Teaching Hospitals.Richmond’s pioneering new set-up enables clients to take advantage of on-site therapeutic consultancy with the optional control benefit of in-patient facilities.Dr Jörg Täubel, Managing Director, commented: “We have developed this platform to embrace the new Phase I patient studies. By basing our units and offices in acute university surroundings, we have developed our Integrated Trials Centre to operate as an SMO for Patient Studies. At the core of our offering is the ‘one centre’ solution – consultants, in-patient facilities and patient panels are all managed and delivered from within the same premises. This enables our clients to benefit from a focused, swift and efficient method of delivering Early Phase studies.”Dr Ulrike Lorch, Medical Director, added: “We are delighted and very excited by the opportunities this move offers our clients. Our new 60 bed unit in Mayday Hospital complements our facilities at St George’s Hospital perfectly. Our Phase I studies are conducted within the safety of acute flagship NHS surroundings, and it’s very pleasing to have consultants in numerous specialities just a door away.”“Our units also provide the in-patient control elements which gives our clients the flexibility to conduct Phase I patient studies, with all the benefits of acute NHS Trust facilities. Of course, our clients can still opt for the more traditionally defined Phase I and II studies; but we now offer far greater choice.” concluded Dr Täubel.

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event